Evidence map›Paper›PMID 34363663›Full record

ArticleJournal of neuropathology and experimental neurology2021

Tau Isoform Profile in Essential Tremor Diverges From Other Tauopathies.

Soong Ho Kim, Kurt Farrell, Stephanie Cosentino, Jean-Paul G Vonsattel, Phyllis L Faust, Etty P Cortes, David A Bennet, Elan D Louis, John F Crary

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neuropathology and experimental neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Developing a Staging Scheme for Essential Tremor: A Discussion of Organizing Principles.Tremor and other hyperkinetic movements (New York, N.Y.) · 2023
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Soong Ho KimDepartment of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Kurt FarrellDepartment of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Stephanie CosentinoCognitive Neuroscience Division, Department of Neurology, Columbia University Medical Center, New York, New York, USA.
Jean-Paul G VonsattelG.H. Sergievsky Center, Columbia University Medical Center, New York, New York, USA.
Phyllis L FaustDepartment of Pathology & Cell Biology, Columbia University Medical Center and the New York Presbyterian Hospital, New York, New York, USA.
Etty P CortesDepartment of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
David A BennetRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois, USA.
Elan D LouisDepartment of Neurology, University of Texas Southwestern, Dallas, Texas, USA.
John F CraryDepartment of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Icahn School of Medicine at Mount Sinai · USColumbia University · USAllen Institute for Brain Science · USColumbia University Irving Medical Center · USRush University Medical Center · USThe University of Texas Southwestern Medical Center · US

Funding

VIRUS-INDUCED BRAIN PATHOLOGYP50AG005131 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BREWER, JAMES B · 1985 to 2018
$55.4M
TREATMENT OF DEPRESSION IN ALZHEIMER'S DISEASEP50AG005133 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KAMBOH, M. ILYAS · 1985 to 2019
$43.0M
UC Irvine Alzheimer's Disease Research Center Induced Pluripotent Stem Cell CoreP50AG016573 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI LAFERLA, FRANK M · 2000 to 2019
$37.0M
UCSD Shiley-Marcos Alzheimer's Disease Research Center P30P30AG062429 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Subhojit Roy · 2019 to 2026
$34.9M
Research Education CoreP30AG066462 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Miguel Arce · 2020 to 2026
$30.1M
The Emory Alzheimer's Disease CenterP50AG025688 · NIA · EMORY UNIVERSITY · PI WALKER, LARY C · 2005 to 2019
$25.7M
Clinical Pathological Study of Cognitive Impairment in Essential TremorR01NS086736 · NINDS · YALE UNIVERSITY · PI COSENTINO, STEPHANIE ANN, LOUIS, ELAN D · 2014 to 2023
$8.1M
ENNCF - Viral Vector CoreP30NS055077 · NINDS · EMORY UNIVERSITY · PI LEVEY, ALLAN I · 2008 to 2018
$6.8M
Regulation of tau expression in Alzheimer disease and agingR01AG054008 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CRARY, JOHN FONDA · 2016 to 2020
$4.0M
Mechanisms of Age-Related TauopathyR01NS095252 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI John Fonda Crary · 2015 to 2026
$3.4M
Post-doctoral fellowship in the mechanisms of age-related tauopathyF32AG056098 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI FARRELL, KURT WILLIAM · 2017 to 2020
$190k
NIA NIH HHS F32 AG056098NIA NIH HHS P30 AG062429NIA NIH HHS P30 AG066462NIA NIH HHS P50 AG005131NIA NIH HHS P50 AG005133NIA NIH HHS P50 AG016573NIA NIH HHS P50 AG025688NIA NIH HHS R01 AG054008NIH HHS R01AG054008NINDS NIH HHS P30 NS055077NINDS NIH HHS R01 NS086736NINDS NIH HHS R01 NS095252
6 · The paper itself

Abstract

Patients with essential tremor (ET) frequently develop concurrent dementia, which is often assumed to represent co-morbid Alzheimer disease (AD). Autopsy studies have identified a spectrum of tau pathologies in ET and tau isoforms have not been examined in ET. We performed immunoblotting using autopsy cerebral cortical tissue from patients with ET (n = 13), progressive supranuclear palsy ([PSP], n = 10), Pick disease ([PiD], n = 2), and AD (n = 7). Total tau in ET samples was similar to that in PSP and PiD but was significantly lower than that in AD. Abnormal tau levels measured using the AT8 phospho-tau specific (S202/T205/S208) monoclonal antibody in ET were similar to those in PSP but were lower than in PiD and AD. In aggregates, tau with 3 microtubule-binding domain repeats (3R) was significantly higher in AD than ET, while tau with 4 repeats (4R) was significantly higher in PSP. Strikingly, the total tau without N-terminal inserts in ET was significantly lower than in PSP, PiD, and AD, but total tau with other N-terminal inserts was not. Monomeric tau with one insert in ET was similar to that in PSP and PiD was lower than in AD. Thus, ET brains exhibit an expression profile of tau protein isoforms that diverges from that of other tauopathies.

Indexed as

AdultAgedAged, 80 and overAlzheimer DiseaseBrainEssential TremorHumansMiddle AgedSupranuclear Palsy, ProgressiveTauopathiestau Proteinstau ProteinsAlzheimer diseaseEssential tremorNeurodegenerationNeurofibrillary tanglePick diseaseProgressive supranuclear palsyTau isoformTauopathy

Identifiers

PMID34363663
PMCPMC8476083
OpenAlexW3190515001

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.